Introduction
N-Acylethanolamines (NAE) are a class of endogenous lipids whose biomedical relevance was highlighted by the discovery that N-arachidonoylethanolamine (anandamide; AEA) binds to and activates the cannabinoid receptors (Devane et al., 1992) . NAE are produced from the corresponding N-acylphosphatidylethanolamines through the action of Ca 2+ -activated D-type phosphodiesterases. Under physiological conditions, NAE occur at low levels in virtually all mammalian cells, tissues and certain body fluids (Bisogno et al., 1999) , and their production is increased by stress, especially under conditions of cell and tissue degeneration (Hansen et al., 2001) . Under these conditions, the greatest increase regards saturated and monounsaturated members of this class of endolipids, all cannabinoid-receptor inactive compounds (Schmid and Berdyshev, 2002) . were available from previous studies (Appendino et al., 2006 , Ech-Chahad et al., 2005 . PEA, PEA oxyhomologues and fatty acid hydroxamates were dissolved in dimethylsulfoxide, all other drugs used were dissolved in the experimental media. Final drug concentrations were obtained by dilution of stock solutions into the experimental media. Final concentration of organic solvents was always less than 0.1%, and they have no effects on cell viability. Drugs were added to the experimental buffer 1 h before the insults, and were maintained for the entire experiment. Cells exposed to solvent alone were considered as controls.
Methods

Drugs and Chemicals
Synthesis of
Cell Cultures
Human neuroblastoma cell lines, SH-SY5Y and SK-N-BE, were cultured in DMEMNutrient Mixture Ham's F12 and DMEM, respectively, supplemented with 10% (v/v) FCS, penicillin (100 IU/ml), streptomycin (100 µg/ml), and L-glutamine (2 mM). The cell culture medium was replaced every 2 days, and the cultures were maintained at 37ºC, 95% air-5% CO 2 in a humidified incubator. The cells were differentiated into neuron-like type by treatment with all-trans-retinoic acid (10 µM), that was added to the cell culture medium every day for either 7 days (SH-SY5Y) or 14 days (SK-N-BE). The day before the experiments, differentiated cells were plated in a six-well culture plate (0.5 -1 10 6 cells/well).
In Vitro Models of Neurodegeneration
Oxidative Stress. The in vitro model of oxidative stress was performed as previously described (Lombardi et al., 2002) . Briefly, differentiated SH-SY5Y cells were washed twice with phosphate buffered saline (PBS) and exposed to t-BOOH (100 µM) in the experimental buffer (in mM: NaCl 138, KCl 2.7, CaCl 2 1.2, MgCl 2 1.2, PBS 10, glucose 10; pH 7.4) for 3 h at 37ºC.
Excitotoxicity.
For the in vitro model of excitotoxicity differentiated SK-N-BE cells were washed twice with PBS and incubated in Neurobasal medium supplemented with B27 (16 h at 37ºC) to increase their sensitivity to the excitotoxic insult. Afterwards, the medium was changed and cells were exposed to 1 mM L-glutamate for 24 h at 37ºC.
Evaluation of Cell Viability and Cell Death
Cell Viability. Cell viability was evaluated with the MTT assay. Absorbance was measured at 570 -630 nm by using an Ultramark microplate reader (Bio-Rad Laboratories, Milan, Italy). The percentage of neuroprotection was calculated as follows:
, where x is the absorbance read in control samples, y is the absorbance read in t-BOOH-or L-glutamate-treated samples, and z is absorbance read in drug-and either t-BOOH-or L-glutamate-treated samples.
Cell Death. Cell death was evaluated by measuring the lactic acid dehydrogenase (LDH) activity in the experimental medium at the end of the experiment by using a commercial kit (Roche Diagnostic, Penzberg, Germany) according to the manufacturer's instructions.
Studies on the Mechanisms of Action
Determination of Free Radical Production. Free radical production was measured by incubating the cells with the fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate as previously described (Lombardi et al., 2002) .
Accumulation of 2',7'-dichlorofluorescein in the cells was measured as an increase in fluorescence at 525 nm, when the sample was excited at 488 nm using a Jasco (FP-777) spectrofluorometer (Jasco International, Tokyo, Japan).
Determination Lipid Peroxidation. Lipid peroxidation was evaluated by measuring the levels of thiobarbituric acid-reacting substances (TBARS) in the cells at the end of the experiments as previously described (Miglio et al., 2004) . Briefly, the cells were washed and harvested with ice-cold 50 mM phosphate buffer, pH 7.4, then 500 µl of 1% thiobarbituric acid and 500 µl of 8 N HCl were added to each sample. The samples were boiled for 20 min and subsequently cooled with tap water. 1-Butanol, 1.5 ml, was then added to the samples and the mixture was shaken for 2 min. After centrifugation at 2000 g for 10 min, the fluorescence intensity at 550 nm (excitation) and 532 nm (emission) in the butanol phase was measured by a Jasco spectrofluorometer.
Measurement of Intracellular Calcium Concentration
Intracellular calcium concentration was measured at single cell level by using a digital calcium image-system. Fura-2-loaded cells (5 10 5 cells/ml) were firmly attached (15 min at 37°C) to poly-L-lysine (0.1 mg/ml)-coated thin (0.2 mm) round glass coverslips (4 cm), washed, transferred to a perfusion chamber (Bioptechs, Butler, PA, USA) and mounted on an inverted microscope (Eclipse TE 300; Nikon, Tokyo, Japan).
Experiments were performed at a chamber temperature of 37°C. All measurements were taken at 40-fold magnification. Excitation wavelengths were alternately selected at Finally, to clarify the role of the hydroxamic group the neuroprotective effects of three fatty acid hydroxamates (2a-c) were tested with the same experimental protocol.
The N-hydroxypalmitamide (2a; 10 µM) abolished the effects of t-BOOH (the EC 50 calculated value was 1.0 µM), while the N-hydroxynonamide (2b) was both less effective (the maximum neuroprotection observed was 36.4 ± 4.7% at 30 µM) and less potent (the EC 50 calculated value was 6.2 µM) than 2a. No neuroprotective effects were observed for the N-hydroxyicosamide (2c) at all concentrations tested (Fig. 2c) .
Effects of Cannabinoid Receptor Antagonists. Previous results from our
laboratory show that PEA oxyhomologues have poor affinity for CB 1 /CB 2 receptors and do not inhibit either the FAAH-mediated AEA hydrolisis or the AMT-mediated AEA cellular uptake (Appendino et al., 2006) . To determine if the neuroprotective effects evoked by these compounds are mediated by cannabinoid receptors, we repeated the above experiments in the presence of AM251, a selective cannabinoid CB 1 receptor antagonist (Gatley et al., 1996) , and AM630, a selective cannabinoid CB 2 receptor antagonist (Ross et al., 1999) . Neither AM251 (10 µM) nor AM630 (10 µM) antagonized the neuroprotective effects induced by increasing concentration (0.1 -30 µM) of either the compound 1b (Fig. 3a) or 2a (Fig. 3b) (Fig. 4c) . Protracted entry of Ca 2+ into neurons is one of the mechanisms leading to excitotoxicity (Choi, 1988) . Therefore, we studied if cell exposure (60 min before L-glutamate) to either ] i increase (F r mean were 0.91 ± 0.07 and 0.92 ± 0.08 respectively; n = 52 for each compound; p < 0.05), whereas PEA (up to 10 µM) had no effect (Fig. 7) . The significant (p < 0.05) [Ca 2+ ] i increase still present, compared to control (L-glutamate-untreated cells), in cells exposed to 1b and 2a supports the residual excitotoxicity (~ 30%) measured (Fig. 6b) .
Discussion
Oxidative stress and excitotoxicity are critical components of series of integrated cellular and biochemical events ("vicious circle") that may culminate in the neuronal death associated to brain ageing and many neurodegenerative conditions, like
Alzheimer's disease (AD), Parkinson's disease (PD), stroke, epilepsy, amyotrophic lateral sclerosis and prion diseases (Lipton and Rosenberg, 1994; Barnham, 2004) .
Exogenous or endogenous compounds capable to prevent or block the progression of these harmful events may be relevant for neuroprotection (Levi and Brimble, 2004) . NAE are endogenous compounds that are part of a protective physiological system providing on-demand defence in case of abnormal neuronal activity (Marsicano et al., 2003) .
Neurodegeneration is associated with a massive accumulation of PEA (Hansen et al.,
2001
), whose neuroprotective effects are, however, still a matter of debate. The beneficial effects, reported in some studies (Skaper et al., 1996) , have been questioned and could not be reproduced by others (Andersson et al., 2000; Franklin et al., 2003) .
Recently, Zolese et al. (2005) demonstrated a combination of both anti-oxidative and
slightly pro-oxidative effects of PEA on Cu 2+ -induced low-density lipoprotein oxidation.
Anti-oxidative effects were observed at low PEA concentrations (0.01 -0.1 µM), while pro-oxidative effects dominated the profile of this compound at higher concentrations (1 µM). From our findings, 30 µM PEA partially (26.3 ± 7.5% in comparison to t-BOOHuntreated cells) protected neurons against oxidative stress, but toxicity was observed at higher (> 30 µM) concentrations. In addition, PEA was incapable to prevent L-glutamateinduced excitotoxicity in our experimental model. Discrepancies in the results from different laboratories might be related to differences in experimental models (i.e., cell culture type, potency of the insult, time exposure to the insult, experimental buffers, chemical stability of solutions), but it seems also clear that the problems associated to the metabolic stability of PEA are compounded by a substantially bi-phasic (anti-or proneurotoxic) profile of activity.
PEA metabolizing enzymes are widely expressed in mammalian tissues, and the cells used for these experiments can, in principle, metabolize PEA and PEA derivatives, since they express FAAH (RT-PCR analysis; data not shown). Therefore, the stabilization of PEA molecule appears to be essential to enhance its bioactivity.
To increase the metabolic stability of PEA and shift its bi-phasic biological profile toward neuroprotection, we modified the polar head group of the molecule. We reasoned that oxyhomologation of the amide bond, while having a stabilizing effect toward enzymatic hydrolysis, because of topologic and electronic changes in the amide bond, should also induce metal chelating properties potentially capable to interfere with oxidative stress (Gaeta and Hider, 2005) . Indeed, when compared to the parent compound, the oxyhomologues of PEA (1b-d) showed greater efficacy and potency in protecting neurons against oxidative stress and excitotoxicity, with N-homologation being more efficient in this respect compared to carbonyl or alkyl oxyhomologation (cf 1b with 1c,d). Spurred by the activity of the N-hydroxyamide 1b, we also investigated the activity of its parent compound, palmitoyl hydroxamic acid (2a). This compound showed potent neuroprotective activity, even larger that than of the oxyhomologues of PEA.
Shortening or lengthening of the acyl chain, as in capryl (C-9; 2b) and arachyl (C-20; 2c)
hydroxamates, led to a decrease of activity, showing that the activity associated to the hydroxamate group is modulated in a specific fashion, by the lipid moiety. While -palmitoyl-N-(2-hydroxyethyl) hydroxylamine retains most of the neuroprotective activity of palmityl hydroxamate despite its decreased chelating properties, is a significant observation, worth pursuing by in a systematic way with a larger sets of substrates.
Remarkably, oxyhomologation had little, if any, effect on the interaction of PEA with cannabinoid receptors and the enzymes involved in the degradation of endocannabinoid (Appendino et al., 2006) . For these reasons, amide oxyhomologues could achieve substantially increased concentrations and a longer half-life at their sites of activity.
Rather than depending on the interaction with cannabinoid receptors and their Taken together, our results suggest that implanting a metal chelating motif on endolipid structures leads not only to an increase of metabolic stability, but also to a potentiation of the neuroprotective properties, without substantially changing the profile of interaction with the endocannabinoid/endovanilloid system and their associated proteins.
Ion metals, particularly iron and copper, play a critical role in both oxidative stress and abnormal metal-protein interaction associated with several neurodegenerative disorders (Zecca et al., 2004; Barnham et al., 2004) . Non-toxic lipophilic brainpermeable iron chelators might offer potential therapeutic benefits for these progressive
diseases. An ideal chelating agent should have the capacity to first scavenging the free redox active metal, present in excess in the brain, into nontoxic and excretable metal complexes, and, secondly, to cap the metal at its labile binding site (i.e. β-amyloid, α-synuclein, prion protein and neuromelanine), preventing any mediated toxic action (Fenton activity and/or aggregation) (Gaeta and Hider, 2005) . Lipids endowed with the hydroxamate group represents an interesting addition to the growing inventory of compounds potentially capable to achieve this goal, and deserves further investigation in in vivo models of neurodegeneration.
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